Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lulu Li
Institutions:
Shandong University of Traditional Chinese Medicine,
Tsinghua Shenzhen International Graduate School
Observed institutions:
Shandong University of Traditional Chinese Medicine,
Tsinghua Shenzhen International Graduate School
ORCID:
0000-0001-6483-3528
Observed ORCID:
0000-0001-6483-3528
OpenAlex ID:
A5077144432
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer
2024
·
Wenjun Huang
, Qingyun Zhu
, et al.
·
Cell Death Discovery
·
90
PDF
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
2024
·
Qingyun Zhu
, Qiuzi Dai
, et al.
·
Cell Death and Disease
·
64
PDF
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy
2024
·
Zhanbo Yang
, Bizhu Chu
, et al.
·
Pharmacological Research
·
44
Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer
2024
·
Weiwen Fan
, Wenkai Li
, et al.
·
European Journal of Pharmaceutical Sciences
·
26
Targeting HDAC and PARP Enhances STING‐Dependent Antitumor Immunity in STING‐Deficient Tumor
2025
·
Chengzhou Mao
, Weiwen Fan
, et al.
·
Advanced Science
·
19
PDF
Design, Synthesis, and Biological Evaluation of Quinoline-Based Hydroxamic Acid Derivatives as Dual DNMT and HDAC Inhibitors with Potent Anti-Breast Cancer Activity
2025
·
Huaxin Lin
, Wenwen Zheng
, et al.
·
Journal of Medicinal Chemistry
·
12
Design, synthesis and biological evaluation of pyrimidine base hydroxamic acid derivatives as dual JMJD3 and HDAC inhibitors
2023
·
Anqi Li
, Wenwen Zheng
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
9
Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence
2026
·
Lulu Li
, Jie Xu
, et al.
·
Translational Oncology
·
4
Gut microbiota and metabolomic features associated with hemoglobin improvement in patients with aplastic anemia: an exploratory clinical multi-omics study
2026
·
Changnian Li
, Yuping Si
, et al.
·
Frontiers in Medicine
PDF
Design and Biological Evaluation of a Potent Dual PARP and BRD4 Inhibitor for Tumor Therapy via Disrupting HRR and BRD4-cJUN-CCL2 Axis
2026
·
Yuling Tan
, Huaxin Lin
, et al.
·
Journal of Medicinal Chemistry
Other primary malignancies are associated with inferior survival in multiple myeloma: a single-center matched retrospective cohort study
2026
·
Changnian Li
, Yaru Wang
, et al.
·
Frontiers in Oncology
PDF
Oral selective estrogen receptor degraders in ER+/HER2− breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative synthesis of adjuvant evidence
2026
·
Bing Guan
, Sijia Zhang
, et al.
·
Frontiers in Oncology
PDF
Shengma Biejia Decoction Suppresses Acute Myeloid Leukemia by Regulating Mitochondrial Dynamics through the PI3K/AKT Signaling Pathway
2026
·
Siyuan Cui
, Wenjian Wei
, et al.
·
Recent Patents on Anti-Cancer Drug Discovery
Multiple myeloma associated with secondary plasma cell leukemia, gastric mucosal extramedullary plasmacytic infiltration, and concurrent moderately differentiated papillary adenocarcinoma: a case report
2026
·
Lulu Li
, Wei Zheng
, et al.
·
Frontiers in Oncology
PDF
Show more works
View as search
Works count:
14
Citation count:
268
H-index:
7
I10-index:
6
Year
Topic
Type